ALLMedicine™ Pap Tests Center
Research & Reviews 228 results
https://doi.org/10.1089/jayao.2022.0013
Journal of Adolescent and Young Adult Oncology; Falk D, Cubbin C et. al.
Apr 28th, 2022 - Purpose: Costs of Papanicolaou (Pap) tests and mammograms are a primary barrier for women aged 18-39 seeking screening and diagnostic services. Race/ethnicity and rural/border resident status compound their risks for delayed diagnosis, possibly re...
https://clinicaltrials.gov/ct2/show/NCT02147418
Apr 22nd, 2022 - While secondary screening strategies have successfully reduced the rate of HPV-positive cervical cancers, an effective screening modality for HPV-OPSCC does not exist. A central problem in the early diagnosis of HPV-OPSCC is the relative inaccessi...
https://doi.org/10.1002/cam4.4655
Cancer Medicine; Amram O, Amiri S et. al.
Mar 20th, 2022 - Studies have shown that cancer screenings dropped dramatically following the onset of the coronavirus diseases 2019 (COVID-19) pandemic. In this study, we examined differences in rates of cervical and colorectal cancer (CRC) screening and diagnosi...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769532
Preventive Medicine; Decker KM, Feely A et. al.
Jan 23rd, 2022 - We evaluated the impact of COVID-19 on cancer screening in Manitoba, Canada using an interrupted time series (ITS) design and data from Manitoba's population-based, organized cancer screening programs from April 2020 to August 2021. In June 2020 (...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628758
Current Oncology (Toronto, Ont.); Ghebrial M, Aktary ML et. al.
Dec 14th, 2021 - Colorectal cancer (CRC) is a leading cause of morbidity and mortality in Canada. CRC screening and other factors associated with early-stage disease can improve CRC treatment efficacy and survival. This study examined factors associated with CRC s...
Clinicaltrials.gov 7 results
https://clinicaltrials.gov/ct2/show/NCT02147418
Apr 22nd, 2022 - While secondary screening strategies have successfully reduced the rate of HPV-positive cervical cancers, an effective screening modality for HPV-OPSCC does not exist. A central problem in the early diagnosis of HPV-OPSCC is the relative inaccessi...
https://clinicaltrials.gov/ct2/show/NCT03061435
May 12th, 2021 - Almost half of all women will develop an HPV infection in their lifetime. While most infections are naturally asymptomatic or cleared by the immune system, some persist and can lead to the development of cervical, vulvar, or anal lesions and event...
https://clinicaltrials.gov/ct2/show/NCT00879840
Nov 17th, 2020 - Background: Currently, there are no convincing early detection approaches for endometrial and ovarian cancers. Although it is well established that some endometrial and ovarian tumors shed cytologically recognizable cells in routinely prepared Pap...
https://clinicaltrials.gov/ct2/show/NCT02264782
Jul 22nd, 2020 - PRIMARY OBJECTIVES: I. To determine the extent to which PreView increases the likelihood that primary care patient participants will receive mammograms, pap tests, colon cancer tests or prostate specific antigen (PSA) testing discussions with prim...
https://clinicaltrials.gov/ct2/show/NCT02494310
Feb 3rd, 2017 - A new mobile diagnostic and treatment unit is being developed by BCH to address the loss-to follow-up associated with the mobile screening program and demonstrate POC diagnosis by HRME. The mobile diagnostic and treatment unit will be equipped wit...
News 101 results
https://www.onclive.com/view/lack-of-access-to-screening-leads-to-more-advanced-cancer-in-socially-and-economically-challenged-populations
Feb 21st, 2022 - Many Americans, particularly those in communities of color or socially and economically challenged populations, are presenting with advanced-stage disease, enduring aggressive treatment, and dying from cancers that should be detected early, accord...
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/298084
Data for the United States on Pap Tests
https://www.medscape.com/viewarticle/949328
Apr 15th, 2021 - The US Department of Health and Human Services (HHS) has proposed overturning rules issued during the Trump administration that effectively prohibit clinicians at Title X–funded health clinics from discussing abortion or referring patients for abo...
https://www.medscape.com/viewarticle/946396
Feb 24th, 2021 - Residual fixatives from liquid-based Pap tests and cervical swabs contain tumor-specific biomarkers for ovarian cancer, according to an analysis of proteins found in matched biospecimens from a woman with high grade serous ovarian cancer. The find...
https://www.mdedge.com/hematology-oncology/article/236214/gynecologic-cancer/pap-test/cervical-swab-samples-can-reveal
Sharon Worcester
Feb 22nd, 2021 - Residual fixatives from liquid-based Pap tests and cervical swabs contain tumor-specific biomarkers for ovarian cancer, according to an analysis of proteins found in matched biospecimens from a woman with high grade serous ovarian cancer. The find.